Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2013
10/15/2013US8558055 Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease
10/15/2013US8557989 Electrochemical affinity biosensor system and methods
10/15/2013US8557978 Cross-linked glycopeptide-cephalosporin antibiotics
10/15/2013US8557973 Detection of nucleic acids by target-specific hybrid capture method
10/15/2013US8557967 Anti-interferon-α antibodies
10/15/2013US8557743 Display library process
10/15/2013US8557609 Imaging electrophoresis system
10/15/2013US8557608 Method for characterizing a local magnetic field, and device for carrying out the method
10/15/2013US8557607 Magnetic nanoparticles
10/15/2013US8557606 Immunological test for detecting autoantibodies against testicular antigens
10/15/2013US8557605 Analyzing methods and devices for biological reactions between a liquid phase and a solid phase
10/15/2013US8557604 Membrane-based lateral flow assay devices that utilize phosphorescent detection
10/15/2013US8557603 Synthetic peptides, methods and kits for diagnosing autoimmune diseases
10/15/2013US8557602 Method for detecting and distinguishing intrahepatic cholangiocarcinoma
10/15/2013US8557601 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
10/15/2013US8557599 Method for automatic determination of sample
10/15/2013US8557598 Method for measuring blood sample and apparatus thereof
10/15/2013US8557597 Total organic carbon measuring instrument
10/15/2013US8557596 Fluorescence detection of nitrogen-containing explosives and blue organic LED
10/15/2013US8557595 Fluorescence detection of nitrogen-containing explosives and blue organic LED
10/15/2013US8557594 Method for determining chromium content in a tungsten matrix with added chromium or simultaneously added chromium and vanadium
10/15/2013US8557593 Mass spectrometric determination of eicosapentaenoic acid and docosahexaenoic acid
10/15/2013US8557592 Reagent kit for detecting lupus anticoagulant and method of determining presence or absence of lupus anticoagulant
10/15/2013US8557591 Methods for assaying percentage of glycated hemoglobin
10/15/2013US8557590 Method for measuring glycated hemoglobin
10/15/2013US8557588 Methods and apparatus for sampling and diluting concentrated emulsions
10/15/2013US8557587 Self-tuning, biologically modeled sorter
10/15/2013US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death
10/15/2013US8557534 Method and compositions for specifically detecting physiologically acceptable polymer molecules
10/15/2013US8557533 Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
10/15/2013US8557532 Diagnosis and treatment of drug-resistant Ewing'S sarcoma
10/15/2013US8557531 Detection of circulating endothelial cells
10/15/2013US8557530 Use of a TAS2R7 nucleic acid sequence to identify modulators
10/15/2013US8557528 Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patients
10/15/2013US8557527 Correlation of molecular markers with clinical outcome in GBM patients radiation treated with or without gefitinib
10/15/2013US8557526 Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
10/15/2013US8557522 Processes for detecting or quantifying more than one nucleic acid in library
10/15/2013US8557515 Compositions and methods for cancer diagnosis and therapy
10/15/2013US8557238 EG-VEGF nucleic acids and polypeptides and methods of use
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013US8557182 Site selectively tagged and templated molecularly imprinted polymers for sensor applications
10/15/2013US8557104 In vitro analyte sensor, and methods
10/15/2013US8557103 Biosensor
10/15/2013US8555708 Robust system and method for obtaining a liquid or gas sample from a multiphase mixture flowing in a hydrocarbon pipeline
10/15/2013US8555705 Fluid storage and dispensing system including dynamic fluid monitoring of fluid storage and dispensing vessel
10/15/2013US8555702 Method for recognizing at least one feature of the fuel in an internal combustion engine
10/15/2013DE202005022103U1 System zur Überwachung und Steuerung der Wassergüte in Naturerlebnisbädern System for monitoring and control of water quality in natural water parks
10/15/2013CA2733166C Analysis system with coding recognition
10/15/2013CA2731040C Ignition interlock breathalyzer
10/15/2013CA2715103C Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods
10/15/2013CA2673085C Transferrin fusion protein libraries
10/15/2013CA2602438C Method and system for measuring water hardness
10/15/2013CA2568238C Methods and compositions for assaying analytes
10/15/2013CA2564826C Non-elispot assay
10/15/2013CA2555699C Monoclonal antibody based biomarker discovery and development platform
10/15/2013CA2548942C Anti-sars monoclonal antibodies
10/15/2013CA2535510C Detecting and profiling molecular complexes
10/15/2013CA2521946C Method of identifying transmembrane protein-interacting compounds
10/15/2013CA2508583C Device for performing measurements and/or taking samples in molten metals
10/15/2013CA2489176C Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells
10/15/2013CA2478970C Micro-devices and analytical procedures for investigation of biological systems
10/15/2013CA2402214C T1r taste receptors and genes encoding same
10/15/2013CA2353643C Methods for producing selected interstrand cross-links in chromosomal nucleic acids and applications thereof
10/15/2013CA2330178C Synthetic peptide vaccines for foot-and-mouth disease
10/11/2013DE202013007536U1 Vorrichtung zur digitalen Ablesung für Schnelltests A digital readout for quick tests
10/10/2013WO2013152325A1 Plasminogen-oxidized phospholipids for the detection of cardiovascular diseases and disorders
10/10/2013WO2013152301A1 O-glycan pathway ovarian cancer signature
10/10/2013WO2013152274A1 Epitope- scaffold immunogens against respiratory syncytial virusm (rsv)
10/10/2013WO2013152203A1 Sample preparation for flow cytometry
10/10/2013WO2013152177A1 Noninvasive measurement of analyte concentration using a fiberless transflectance probe
10/10/2013WO2013152163A1 Method and apparatus for detecting the presence of water in a current of liquid hydrocarbons
10/10/2013WO2013152076A1 Compositions and methods for treating hypertension
10/10/2013WO2013152047A1 Methods and compositions for diagnosis and prognosis of sepsis
10/10/2013WO2013152011A1 Novel human control antibodies and uses therefor
10/10/2013WO2013152010A1 Reagents, methods, and kits for the classification of cancer
10/10/2013WO2013151979A1 Outer membrane proteins of histophilus somni and methods thereof
10/10/2013WO2013151756A1 Electrodes for sensing chemical composition
10/10/2013WO2013151727A1 Heparin-bulking agent compositions and methods thereof
10/10/2013WO2013151726A1 Srm methods in alzheimer's disease and neurological disease assays
10/10/2013WO2013151697A1 Methods and compounds for identifying glycosyltransferase inhibitors
10/10/2013WO2013151688A1 Methods and compositions for using insulin-like growth factor binding protein 6 in treating and diagnosing diabetes
10/10/2013WO2013151600A1 System and process for selective detection of vapor-phase analytes
10/10/2013WO2013151594A2 Catulin as a marker and therapy target for highly motile squamous cell carcinoma metastatic cells and normal wound healing
10/10/2013WO2013151577A1 Interrogatory cell-based assays and uses thereof
10/10/2013WO2013151538A1 Fluorescent labeling of living cells
10/10/2013WO2013151532A1 Apparatus and method for molecular separation, purification, and sensing
10/10/2013WO2013151511A1 Modified Dual-Colour Protein
10/10/2013WO2013151464A2 Method for determining the content of a ligand in a sample (alternatives)
10/10/2013WO2013151413A1 Methods and compositions for determining increased risk for breast cancer
10/10/2013WO2013151310A1 Trans-illuminator using leds
10/10/2013WO2013151135A1 Microarray processing apparatus, well plate for microarray processing apparatus, microarray holder, and microarray cleaning method
10/10/2013WO2013151122A1 Method and kit for immunological detection of mycobacterium tuberculosis complex
10/10/2013WO2013151066A1 Method for detecting or quantifying analyte, kit for detecting or quantifying analyte, and test strip for lateral flow chromatography used to detect or quantify analyte
10/10/2013WO2013151058A1 DNA CONTROLLING miR-140 EXPRESSION, AND SCREENING METHOD OF DRUGS USING SAID DNA
10/10/2013WO2013151053A1 Method for examining arteriosclerosis
10/10/2013WO2013151026A1 Diagnostic marker and diagnostic method for cancer cell resistant to pi3k inhibitor
10/10/2013WO2013150518A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
10/10/2013WO2013150432A1 Container with separable chambers for the treatment of biological tissues by centrifugal separation
10/10/2013WO2013150306A1 Photovoltaic sensor arrays
10/10/2013WO2013150291A1 A method for measuring performance of a spectroscopy system